|
2021 |
An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2016 |
Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. |
Nam Lee, Ph.D. |
|
2016 |
Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. |
Roberta Diaz Brinton, Ph.D |
|
2022 |
Age-Induced Changes in μ-Opioid Receptor Signaling in the Midbrain Periaqueductal Gray of Male and Female Rats. |
John M. Streicher, PhD |
|
2022 |
Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D. |
|
2020 |
Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2025 |
Accuracy of survey-based assessment of eligibility for medication abortion compared with clinician assessment. |
Sigrid Gardner Williams |
|
2022 |
A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment. |
Roberta Diaz Brinton, Ph.D, Kathleen Rodgers, Ph.D., Fei Yin, Ph.D. |
|
2022 |
A prolactin-dependent sexually dimorphic mechanism of migraine chronification. |
Edita Navratilova, Frank Porreca, PhD |
|
2020 |
A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models. |
John M. Streicher, PhD |
|
2019 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. |
Tally Largent-Milnes, PhD, Kathleen Rodgers, Ph.D., Todd Vanderah, PhD |
|
2018 |
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2012 |
A dominant negative ERβ splice variant determines the effectiveness of early or late estrogen therapy after ovariectomy in rats. |
Roberta Diaz Brinton, Ph.D |
|
2010 |
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss. |
Tally Largent-Milnes, PhD, Patrick W Mantyh, Todd Vanderah, PhD |
|
2011 |
2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
|
2011 |
17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. |
Roberta Diaz Brinton, Ph.D |
|
2012 |
17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. |
John M. Streicher, PhD |
|
2017 |
16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. |
|
|
2016 |
(S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5. |
|
